[1] |
|
[2] |
LING C, BACOS K, RÖNN T. Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine?[J]. Nat Rev Endocrinol, 2022, 18(7):433-448. DOI: 10.1038/s41574-022-00671-w.
|
[3] |
STÖHR J, BARBARESKO J, NEUENSCHWANDER M,et al. Bidirectional association between periodontal disease and diabetes mellitus:a systematic review and meta-analysis of cohort studies[J]. Sci Rep, 2021, 11(1):13686. DOI: 10.1038/s41598-021-93062-6.
|
[4] |
MIRNIC J, DJURIC M, GUSIC I,et al. Effects of nonsurgical periodontal therapy on salivary 8-hydroxy-deoxyguanosine levels and glycemic control in diabetes mellitus type 2 patients[J]. Biomedicines, 2022, 10(9):2269. DOI: 10.3390/biomedicines10092269.
|
[5] |
KITAMOTO S, NAGAO-KITAMOTO H, JIAO Y Z,et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis[J]. Cell, 2020, 182(2):447-462.e14. DOI: 10.1016/j.cell.2020.05.048.
|
[6] |
FENG Y K, WU Q L, PENG Y W,et al. Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice[J]. J Neuroinflammation, 2020, 17(1):347. DOI: 10.1186/s12974-020-02027-5.
|
[7] |
ZHOU N, ZOU F G, CHENG X,et al. Porphyromonas gingivalis induces periodontitis,causes immune imbalance,and promotes rheumatoid arthritis[J]. J Leukoc Biol, 2021, 110(3):461-473. DOI: 10.1002/JLB.3MA0121-045R.
|
[8] |
LIU Y M, HUANG W K, DAI K,et al. Inflammatory response of gut,spleen,and liver in mice induced by orally administered Porphyromonas gingivalis[J]. J Oral Microbiol, 2022, 14(1):2088936. DOI: 10.1080/20002297.2022.2088936.
|
[9] |
DONALDSON G P, LEE S M, MAZMANIAN S K. Gut biogeography of the bacterial microbiota[J]. Nat Rev Microbiol, 2016, 14(1):20-32. DOI: 10.1038/nrmicro3552.
|
[10] |
MULHALL H, HUCK O, AMAR S. Porphyromonas gingivalis,a long-range pathogen:systemic impact and therapeutic implications[J]. Microorganisms, 2020, 8(6):869. DOI: 10.3390/microorganisms8060869.
|
[11] |
BAO J, LI L L, ZHANG Y H,et al. Periodontitis may induce gut microbiota dysbiosis via salivary microbiota[J]. Int J Oral Sci, 2022, 14(1):32. DOI: 10.1038/s41368-022-00183-3.
|
[12] |
SHI C, CAI L T, XUN Z,et al. Metagenomic analysis of the salivary microbiota in patients with caries,periodontitis and comorbid diseases[J]. J Dent Sci, 2021, 16(4):1264-1273. DOI: 10.1016/j.jds.2020.12.002.
|
[13] |
MA J L, KAGEYAMA S, TAKESHITA T,et al. Clinical utility of subgingival plaque-specific bacteria in salivary microbiota for detecting periodontitis[J]. PLoS One, 2021, 16(6):e0253502. DOI: 10.1371/journal.pone.0253502.
|
[14] |
HE J Y, HUANG W J, PAN Z W,et al. Quantitative analysis of microbiota in saliva,supragingival,and subgingival plaque of Chinese adults with chronic periodontitis[J]. Clin Oral Investig, 2012, 16(6):1579-1588. DOI: 10.1007/s00784-011-0654-4.
|
[15] |
NASCIMENTO J C, MATHEUS V A, OLIVEIRA R B,et al. High-fat diet induces disruption of the tight junction-mediated paracellular barrier in the proximal small intestine before the onset of type 2 diabetes and endotoxemia[J]. Dig Dis Sci, 2021, 66(10):3359-3374. DOI: 10.1007/s10620-020-06664-x.
|
[16] |
JIN R, NING X Q, LIU X,et al. Porphyromonas gingivalis-induced periodontitis could contribute to cognitive impairment in Sprague-Dawley rats via the P38 MAPK signaling pathway[J]. Front Cell Neurosci, 2023, 17:1141339. DOI: 10.3389/fncel.2023.1141339.
|
[17] |
CHOPYK D M, GRAKOUI A. Contribution of the intestinal microbiome and gut barrier to hepatic disorders[J]. Gastroenterology, 2020, 159(3):849-863. DOI: 10.1053/j.gastro.2020.04.077.
|
[18] |
LI Q W, GAO Z Z, WANG H,et al. Intestinal immunomodulatory cells(T lymphocytes):a bridge between gut microbiota and diabetes[J]. Mediators Inflamm, 2018, 2018:9830939. DOI: 10.1155/2018/9830939.
|
[19] |
YUAN N, ZHANG H F, WEI Q,et al. Expression of CD4+CD25+Foxp3+ regulatory T cells,interleukin 10 and transforming growth factor β in newly diagnosed type 2 diabetic patients[J]. Exp Clin Endocrinol Diabetes, 2018, 126(2):96-101. DOI: 10.1055/s-0043-113454.
|
[20] |
PREISSER T M, DA CUNHA V P, SANTANA M P,et al. Recombinant Lactococcus lactis carrying IL-4 and IL-10 coding vectors protects against type 1 diabetes in NOD mice and attenuates insulitis in the STZ-induced model[J]. J Diabetes Res, 2021, 2021:6697319. DOI: 10.1155/2021/6697319.
|
[21] |
SATO K, TAKAHASHI N, KATO T,et al. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system[J]. Sci Rep, 2017, 7(1):6955. DOI: 10.1038/s41598-017-07196-7.
|
[22] |
FENG Y, CHEN Z, TU S Q,et al. Role of interleukin-17A in the pathomechanisms of periodontitis and related systemic chronic inflammatory diseases[J]. Front Immunol, 2022, 13:862415. DOI: 10.3389/fimmu.2022.862415.
|
[23] |
CHEN L, RUAN G C, CHENG Y,et al. The role of Th17 cells in inflammatory bowel disease and the research progress[J]. Front Immunol, 2022, 13:1055914. DOI: 10.3389/fimmu.2022.1055914.
|
[24] |
DENG Z Z, WANG S F, WU C F,et al. IL-17 inhibitor-associated inflammatory bowel disease:a study based on literature and database analysis[J]. Front Pharmacol, 2023, 14:1124628. DOI: 10.3389/fphar.2023.1124628.
|
[25] |
HONG C P, PARK A, YANG B G,et al. Gut-specific delivery of T-helper 17 cells reduces obesity and insulin resistance in mice[J]. Gastroenterology, 2017, 152(8):1998-2010. DOI: 10.1053/j.gastro.2017.02.016.
|
[26] |
ZHOU X, JOHNSON J S, SPAKOWICZ D,et al. Longitudinal analysis of serum cytokine levels and gut microbial abundance links IL-17/IL-22 with Clostridia and insulin sensitivity in humans[J]. Diabetes, 2020, 69(8):1833-1842. DOI: 10.2337/db19-0592.
|
[27] |
GEORGE L, RAMASAMY T, SIRAJUDEEN K,et al. LPS-induced apoptosis is partially mediated by hydrogen sulphide in RAW 264.7 murine macrophages[J]. Immunol Invest, 2019, 48(5):451-465. DOI: 10.1080/08820139.2019.1566355.
|
[28] |
JIA L, WU R Q, HAN N N,et al. Porphyromonas gingivalis and Lactobacillus rhamnosus GG regulate the Th17/Treg balance in colitis via TLR4 and TLR2[J]. Clin Transl Immunology, 2020, 9(11):e1213. DOI: 10.1002/cti2.1213.
|
[29] |
KUO W T, ODENWALD M A, TURNER J R,et al. Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival[J]. Ann N Y Acad Sci, 2022, 1514(1):21-33. DOI: 10.1111/nyas.14798.
|
[30] |
|
[31] |
READ E, CURTIS M A, NEVES J F. The role of oral bacteria in inflammatory bowel disease[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(10):731-742. DOI: 10.1038/s41575-021-00488-4.
|